• HOME
  • ABOUT US
  • PRODUCTS
    • LIST OF COPP
    • LIST OF PRODUCTS
  • CAREER
  • BLOG
  • CONTACT US
  • HOME
  • ABOUT US
  • PRODUCTS
    • LIST OF COPP
    • LIST OF PRODUCTS
  • CAREER
  • BLOG
  • CONTACT US

Vitamin D intake decreases colitis risk in cancer patients on immune checkpoint inhibitors

July 6, 2020
-
News
-
Posted by seoaccount medivisual
vitamin-d-intake-admac

What’s New

In cancer patients receiving immune checkpoint inhibitors, the administration of Vitamin D supplements can diminish the incidence of colitis.

A novel research depicted that in patients treated with ICIs (immune checkpoint inhibitors), taking vitamin D supplements is linked with reduced risk for the development of ICI colitis (a potentially serious side effect of anti-cancer therapy).

ICIs aid the immune system to identify and fight with the cancer cells. Although these treatment regimens have been valuable for many cancer patients, they can cause an intense inflammatory reaction in the colon. ICI-induced colitis can lead to discontinuation of treatment and restrict the usage of such life-saving drugs.

Colitis is one of the most severe and common adverse effects of cancer immunotherapy. However, to avoid the colitis incidence, there is a paucity of understanding of the risk factors that could be altered. Previous studies have elucidated that in cases of autoimmune diseases and inflammatory bowel disease, the administration of vitamin D may affect the immune system.

Thus, a retrospective study was conducted in cancer patients to examine whether vitamin D supplements intake might diminish the risk of colitis in patients receiving ICIs. Between 2011 and 2017, the study included information on 213 melanoma patients receiving ICIs. Colitis was found to occur in 37 (17 %) patients. Before initiating treatment with ICIs, 66 patients (31%) took vitamin D supplements. It was found that subjects who took vitamin D had 65 % lower odds of developing colitis.

In another cohort of 169 patients, these findings were further substantiated. Overall, colitis occurred in 49 patients (29 %). The administration of vitamin D in this group was found to be linked with 54 % lower odds of developing colitis. The close association between vitamin D intake and minimized risk for colitis incidence could potentially affect clinical practice if authenticated in future prospective studies.

Further testing of Vitamin D supplementation is warranted. These tests should examine whether Vitamin D intake in cancer patients could be a safe, easily accessible, and cost-effective approach towards preventing gastrointestinal toxicity and extending the effectiveness of ICIs treatment.

Reference:

https://www.sciencedaily.com/releases/2020/06/200622095018.htm

https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32966?af=R

← PREVIOUS POST
Dried Fruits: The quintessential food for cancer patients
NEXT POST →
Artificial sweeteners: Good or Bad for cancer patients?

Related News

Other posts that you should not miss.
Lurbinectedin-receives-FDA-approval-admac

Lurbinectedin receives FDA-approval to treat metastatic SCLC

August 7, 2020
-
News

For adult patients with metastatic SCLC (small cell lung cancer) with disease progression on or after platinum-based chemotherapy, lurbinectedin (ZEPZELCA, Pharma Mar S.A.) received FDA (Food and Drug …

Read More →
Posted by seoaccount medivisual
1 MIN READ
Ellagic-acid-Cancer-fighting-food-ingredient-admac

Ellagic acid: Cancer-fighting food ingredient

July 15, 2020
-
News

Worldwide, cancer is a major cause of death. In recent years, numerous plant-derived compounds have gained attention as alternative cancer remedies for improving the prevention and treatment of …

Read More →
Posted by seoaccount medivisual
5 MIN READ
wogonin-for-cancer-treatment-admac

Anticancer flavonoid wogonin for cancer treatment

August 25, 2020
-
News

Worldwide, cancer has created havoc and has posed a substantial burden on patients and the healthcare system. To combat cancer, numerous treatments such as chemotherapy, radiation therapy, surgery, …

Read More →
Posted by seoaccount medivisual
4 MIN READ
Please speak to us:
  • Phone:+91 172 2565161 , +91 172 2565162
  • Email : admac@admacinternational.com
Admac House
SCO 84, Sector 5,
Panchkula (Haryana)
134112 INDIA.
Our aim

At Admac we aim at providing innovative World-Standard medicines for all, at affordable prices. Admac is fully committed towards WHO standards; quality & growth, latest technology & R & D with sheer hard work and dedicated team work.

All Rights Reserved. 2016
Powered  by: Admac Oncology
Vitamin D intake decreases colitis risk in cancer patients on immune checkpoint inhibitors - ADMAC Life Science